Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
Launched by UNIVERSITY OF HOUSTON · Aug 4, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how experiences of microaggressions—small, often unintentional acts of discrimination—affect smoking behaviors among Latinx adults. Researchers want to understand if these negative experiences relate to how much people smoke, how they feel when they can't smoke, and their cravings for cigarettes. They are also looking at whether not being able to smoke influences this relationship.
To participate in the study, you need to be at least 18 years old, a regular smoker for at least a year (smoking at least five cigarettes a day), and identify as Hispanic or Latino. You should also have experienced at least one microaggression in the last six months. If you join, you can expect to share your experiences and participate in assessments related to your smoking and feelings about it. It's important to note that people with certain mental health issues, those who are pregnant, or those with active suicidal thoughts cannot participate. This study aims to shed light on important connections between discrimination and smoking, which could help develop better support for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years of age or older
- • Current regular (daily) cigarette smoking for \>= 1 year
- • Current smoking \>= 5 cig/day and biochemically confirmed via carbon monoxide (CO) analysis
- • Being self-identified as Hispanic or Latino
- • Able to provide written, informed consent
- • Endorsement of at least one microaggression experience over the past 6-months
- Exclusion Criteria:
- • Endorsement of current psychotic symptoms
- • Active suicidality
- • Currently pregnant
About University Of Houston
The University of Houston is a leading research institution dedicated to advancing knowledge and innovation across various disciplines, including clinical research. With a commitment to enhancing public health and well-being, the university actively sponsors clinical trials that explore new treatments and interventions. Leveraging its robust academic resources and expertise, the University of Houston fosters collaboration among researchers, healthcare professionals, and community partners to address pressing health challenges and contribute valuable insights to the medical field. Through its clinical trial initiatives, the university aims to translate research findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Brooke Y Kauffman, Ph.D.
Principal Investigator
University of Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials